KJ Muldoon
Kyle Muldoon Jr.
≈ 2 min read
KJ Muldoon. encyclopegia.org, snapshot enwiki-001366303472. /a/kj-muldoon
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Kyle Muldoon Jr. (medical identification KJ, born 1 August 2024) is the first person to have received personalized gene therapy using CRISPR gene editing. Born with an extremely rare (one in a million) genetic condition with metabolic disorder, called the neonatal-onset carbamoyl phosphate synthetase I (CPS1) deficiency, he was given a genome tailored gene for CPS1 in 20251 that helped him to acquire normal urea cycle and normal ammonia metabolism.
The gene-editing technique for his condition was developed by David Liu's lab in 2016-2017, and designed by Rebecca C. Ahrens-Nicklas and Kiran Musunuru in 2024 for KJ's mutation, and treatment was completed in April 2025, which was reported in The New England Journal of Medicine. He is listed in the Nature 's 10 of 2025 as the "Trailblazing baby" as the first person saved by personalized CRISPR gene editing.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1366303472 under CC BY-SA 4.0; modifications have been made.
References
1 claim could not be tied to a specific sentence and is listed in the table below instead.
- ↩Wikipedia “KJ Muldoon” date of birth (×1) · confidence 0.95 revision URL